Randomized Placebo-Controlled Phase II Study of Dasatinib with Standard Chemo-Radiotherapy for Newly Diagnosed Glioblastoma (GBM), N0877
- Citation:
- J Clin Oncol vol 33 (suppl) abstr 2013
- Meeting Instance:
- ASCO 2015
- Year:
- 2015
- Type:
- Abstract
- Sub type:
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- Nadia Laack Eva Galanis S. Keith Anderson Clinton Leinweber Jan Buckner Caterina Giannini Francois Geoffroy Derek R. Johnson Glenn J. Lesser Kurt Jaeckle Jann Sarkaria
- Networks:
- HEARTLAND, LAPS-MN026, NC002, NC012
- Study
- NCCTG-N0877
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 1/2
- Keywords: